Stichting DON
- Company typePrivate
- Founded2006
- HeadquartersAmsterdam, Netherlands
- Headcount1–10
- GTM typeB2C
- OfferingServices
Stichting DON firmographics
Firmographics- Name
- Stichting DON
- Legal name
- Stichting Diabetes Onderzoek Nederland
- Website
- https://stichtingdon.nl
- Company type
- Private
- Founded year
- 2006
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Ownership category
- akta.pro rank
Stichting DON industry classification
Industry- Product category
- Nonprofit Health Research Foundation
- NAICS
- Voluntary Health Organizations (813212), Grantmaking Foundations (813211), Scientific Research and Development Services (5417)
- SIC
- Services-Health Services (8000), Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Health & Medical Research Grantmaking Foundations (BPAGAKAL)
- akta.pro secondary industries
- Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS) (BPAGACAA), Research & Science Grantmaking Foundations (BPAGAKAI)
Keywords
Where Stichting DON is headquartered
LocationHeadquarters
- HQ city
- Amsterdam
- HQ country
- Netherlands
- HQ region
- Europe
Offices1 record
Markets served
Stichting DON business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Marketing or Sales, Operations, Others, Infrastructure
Revenue model
- One-time Donations: Individual donors make one-time gifts through online donation tools. Every euro goes directly to research for curing Type 1 Diabetes.
- Multi-year Partnership Donations: Multi-year donors commit to supporting DON for five years with minimum 1,000 euro annual donations. They receive research updates and lab visits. This creates sustainable, predictable funding for long-term research projects.
- Legacy/Bequest Giving: DON accepts inheritances through wills. Options include: full inheritance designation, specific bequests (legacies), or Named Funds where donors determine the name and direction within DON's mission. DON has ANBI status, making legacies tax-free.
- Event Fundraising: Revenue generated from events like the DON Masters (golf tournament), DON Open (padel), and other fundraising events. The 2024 DON Masters raised over 300,000 euros.
- Corporate Partnerships: Business partnerships where companies support DON's mission, such as Abbott sponsoring the podcast 'Insuline mijn benzine' and Cycle Software sponsoring the DON Open.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Pay-as-you-go | One-time donation - flexible amount chosen by donor |
| Subscription | Annual | Multi-year partner donation - minimum 1,000 euros over 5 years |
Go-to-market motion2 records
Distribution channels4 records
Marketing channels7 records
Stichting DON product offering
Product offeringCore offering
Stichting DON is a Dutch charitable foundation that raises and channels donations exclusively toward curing Type 1 Diabetes (T1D). It operates Cure One, a dedicated research center co-founded with Leiden University Medical Center (LUMC), and funds research into stem cell islet transplantation, immune therapy using dendritic cells, fecal microbiota transplantation, and vaccine development. DON offers one-time donations, multi-year partnership donations (minimum €1,000/year for five years), legacy/bequest giving, a DIY fundraising platform, and signature fundraising events such as the DON Masters golf tournament and DON Open padel event.
Product overview
Stichting DON (Diabetes Onderzoek Nederland) is a Dutch charitable foundation that functions as a fundraising and research acceleration organization for type 1 diabetes cure research. The organization operates Cure One, a specialized research center co-founded with LUMC in Leiden, as its core initiative. DON's portfolio includes donation programs (one-time, multi-year, and legacy giving), a DIY fundraising platform for supporters, and major fundraising events such as the DON Masters golf tournament. Additionally, DON produces the 'Insuline mijn benzine' podcast series for awareness and education. The organization connects researchers, donors, partners, and ambassadors to accelerate the path from laboratory to patient, focusing exclusively on cure research rather than symptom management.
Differentiator
Problem solved
Functional benefit
Brands
- Cure One: A specialized research center dedicated to developing curative treatments for type 1 diabetes, established in partnership with Leiden University Medical Center (LUMC).
Products and services
- Cure One Research Center A specialized research center co-founded with Leiden University Medical Center (LUMC), fully dedicated to developing and applying curative treatments for type 1 diabetes. The center focuses on stem cell islet transplantation, immune therapy, and regenerative medicine approaches, with the goal of becoming a leading European hub for T1D cure research.
- One-time Donation Single online donation option allowing supporters to contribute directly to DON's T1D cure research funding efforts through the website's secure donation tool with flexible amount selection. Every euro goes directly to research, as organizational costs are covered by a separate donor group.
- Multi-year Donation Program Recurring donation program where supporters commit to five years of donations with a minimum of €1,000 per year. Multi-year donors receive research updates and are welcome to visit the researchers' laboratory. Periodical gifts are tax-deductible in the Netherlands, providing nearly 50% more value for DON than the net cost to the donor.
- Legacy Giving (Nalatenschap) Bequest and legacy giving program allowing supporters to include DON in their testament. Options include inheritance designation (erfstelling), fixed legacy (legaat), or Named Fund (Fonds op Naam) with personalized direction within DON's mission. Tax-advantaged through DON's ANBI status.
- DIY Fundraising Platform Online action platform (actievoorstichtingdon.nl) enabling supporters to create personal fundraising campaigns for DON for events, birthdays, or other activities, including access to professional fundraising website tools and promotional materials.
- DON Masters Golf Tournament Annual golf tournament serving as a major fundraising initiative, bringing together supporters for networking and sport while raising funds for T1D research. The 2024 edition raised over €300,000.
- Podcast 'Insuline mijn benzine' Six-episode podcast series hosted by Maarten de Gruyter (DON founder) and ambassador Roxanne Kwant, discussing life with type 1 diabetes, covering topics including sex, drugs, puberty, sports, pregnancy, acceptance, and scientific developments toward a cure. Sponsored by Abbott.
Quantifiable outcome
- Clinical trial results: 10 out of 12 patients who received stem cell islet transplants no longer need insulin
- +1 more outcomes
Companies that use Stichting DON
Customer profileNamed customers3 records
Segments1 record
Ideal customer profiles4 records
Stichting DON technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration6 records
Feature4 records
Stichting DON partnerships and signals
Strategic signalPartnerships
Seven partnerships are on record, tiered core and minor.
- Diabetes FondscoreStrategic partnership announced on World Diabetes Day. Diabetes Fonds brings expertise and network to support Cure One's mission. Both organizations share the goal of curing Type 1 Diabetes through international collaboration.
- Leids Universitair Medisch Centrum (LUMC)coreCure One research center established in partnership with LUMC in Leiden. DON serves as co-founder, fundraiser, and strategic partner. DON invests annual base financing and brings entrepreneurship, strategic focus, and network to accelerate scientific breakthroughs to patients. Cure One aims to cure Type 1 Diabetes through stem cell therapy and other regenerative treatments.
- AbbottminorAbbott, producer of FreeStyle Libre systems, sponsored the podcast 'Insuline mijn benzine' and Suzannes marathon vlog series. Abbott has no influence on content - shared opinions are those of the creators.
- Cycle SoftwareminorSponsored the DON Open 2026 padel event, contributing to the 7,500 euro fundraising total.
- SimpelZodiak (TV Production)minorProduction company of Football Island reality show. When Frank de Boer won and chose DON as charity, SimpelZodiak donated 50,000 euros to DON.
- Roland Berger (Strategic Advisory)minorInternational strategic advisory firm hired in 2024 to analyze how DON can best contribute within the research, drug development, and market introduction chain for Type 1 Diabetes cure.
- DiabetercoreTreatment center in Amsterdam collaborating with Prof. Nieuwdorp's research, providing access to a cohort of nearly 4,000 T1D patients for large-scale gut bacteria studies. Also helping select patients for clinical trials.
Scale indicators8 records
Recent moves8 records
Expansion highlights6 records
Stichting DON competitors and assessment
Company assessmentBroad incumbents
- International Diabetes Federation (IDF): IDF is the global umbrella organization for national diabetes associations, representing over 230 associations across 170 countries. While much broader in scope than DON, IDF's policy advocacy and research funding work intersects with DON's mission at the international level, particularly around World Diabetes Day where Cure One was launched.
Regional players
- Diabetes Australia: Diabetes Australia is the national peak body for diabetes in Australia, funding research and supporting people with diabetes. Operates a similar research grantmaking and donor stewardship model but in a different geography and with broader scope. Comparable as a national-level diabetes foundation peer.
- American Diabetes Association: The American Diabetes Association is the largest US diabetes organization, funding research, advocacy, and education across all diabetes types. Operates a broader research portfolio than DON and serves a different geography, but its scale and grantmaking infrastructure make it a relevant comparator for mature-stage diabetes nonprofit operations.
- Diabetes UK: Diabetes UK is the UK's leading diabetes charity, funding research and supporting people with all types of diabetes. Operates a similar grantmaking + research funding + donor stewardship model but in a different geography and with broader scope (all diabetes types), making it a regional rather than direct peer.
Direct peers
- T1D Exchange: T1D Exchange is a US-based nonprofit driving T1D research through a large patient registry and clinical research network. Like DON, it focuses exclusively on Type 1 Diabetes and accelerates research via coordinated patient cohorts — comparable to DON's Diabeter partnership accessing 4,000 patients. T1D Exchange emphasizes real-world data, DON emphasizes cure research.
- JDRF (Breakthrough T1D): JDRF (now Breakthrough T1D) is the world's leading T1D research foundation, with a mission nearly identical to Stichting DON: funding cure research for Type 1 Diabetes. Both operate multi-year donor programs, fund stem cell and immune therapy research, and run ambassador/event-driven fundraising. JDRF is the global benchmark DON models itself against.
- Diabetes Fonds: Diabetes Fonds is the largest Dutch diabetes research charity and a direct domestic peer of DON. While Diabetes Fonds covers all diabetes types, both organizations compete for Dutch donor mindshare and have recently entered a strategic partnership around Cure One. They are the two dominant nonprofit brands in the Dutch diabetes funding landscape.
- Beyond Type 1: Beyond Type 1 is a US-based nonprofit focused exclusively on Type 1 Diabetes, combining community storytelling, ambassador-led awareness, and research grantmaking. Mirrors DON's emphasis on personal stories, ambassador networks, and T1D-specific funding, though DON is more research-curation oriented while Beyond Type 1 leans digital advocacy.
- Diabetes Research Institute Foundation (DRIF): DRIF is the US nonprofit fundraising arm of the Diabetes Research Institute, focused on a biological cure for T1D through islet transplantation and immune modulation. Directly analogous to DON's Cure One model — a dedicated research center, donor-funded, with a cure-not-management mandate. Comparable structure and mission.
Others
- Helmsley Charitable Trust (T1D Program): Helmsley Charitable Trust is a major private foundation with one of the largest T1D cure research portfolios globally. It is both a co-financier of Cure One's immune therapy trial and a strategic partner/funder. While not a peer in the fundraising sense, Helmsley is a critical ecosystem participant whose funding decisions materially affect DON's research pipeline.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Stichting DON social profiles
Digital presenceStichting DON financial estimates
Financial estimateRevenue estimate
Valuation estimate
Stichting DON leadership team
Management profileNumber of profiles
Profiles16 records
Stichting DON funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Stichting DON M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Stichting DON
What does Stichting DON do?
Stichting DON is a Dutch charitable foundation that raises and channels donations exclusively toward curing Type 1 Diabetes (T1D). It operates Cure One, a dedicated research center co-founded with Leiden University Medical Center (LUMC), and funds research into stem cell islet transplantation, immune therapy using dendritic cells, fecal microbiota transplantation, and vaccine development. DON offers one-time donations, multi-year partnership donations (minimum €1,000/year for five years), legacy/bequest giving, a DIY fundraising platform, and signature fundraising events such as the DON Masters golf tournament and DON Open padel event.
Is Stichting DON a public or private company?
Stichting DON is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was Stichting DON founded?
Stichting DON was founded in 2006. It employs 1 to 10 people.
Where is Stichting DON based?
Stichting DON is headquartered in Amsterdam, Netherlands, in the Europe region.
How does Stichting DON make money?
Five revenue lines are on record. One-time Donations are the primary driver. The others are multi-year Partnership Donations, legacy/Bequest Giving, event Fundraising and corporate Partnerships.
Who are Stichting DON's main competitors?
International Diabetes Federation (IDF) is listed as a broad incumbent. Regional players are Diabetes Australia, American Diabetes Association and Diabetes UK. Direct peers are T1D Exchange, JDRF (Breakthrough T1D), Diabetes Fonds, Beyond Type 1 and Diabetes Research Institute Foundation (DRIF). Helmsley Charitable Trust (T1D Program) is listed as an others.
Does Stichting DON have an API?
No public API is recorded for Stichting DON.
What industry is Stichting DON in?
Stichting DON's product category is Nonprofit Health Research Foundation. Its primary akta.pro industry code is BPAGAKAL, Health & Medical Research Grantmaking Foundations, with a secondary code of BPAGACAA, Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS). Its NAICS code is 813212 and its SIC code is 8000.